Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. - Wikidata - wikimedia - TriplyDB

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q44461372

about

Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias Risk definition and management strategies in retinoblastoma: current perspectives Clinical and biological features of acute myeloid leukaemia occurring as second malignancy: GIMEMA archive of adult acute leukaemia.Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.Remission death in acute lymphoblastic leukaemia: a changing pattern Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia.Genes and environment: effects on the development of second malignancies in retinoblastoma survivors.Detection of minimal residual disease in acute leukemia by flow cytometry.A critical risk-benefit assessment argues against the use of anthracyclines in induction regimens for newly diagnosed childhood acute lymphoblastic leukemia.Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group.Chemotherapy of secondary leukemias.Treating cancer patients. Practical monitoring and management of therapy-related complications.Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes.Leukemias related to treatment with DNA topoisomerase II inhibitors.Clinical and epidemiological features of acute lymphoblastic leukemia following a previous malignancy.Therapy related leukemias: susceptibility, prevention and treatment.Therapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimens.Involvement of the ALL-1 gene in a solid tumor.Myeloid leukemia after hematotoxins.Subsequent malignant neoplasms in pediatric patients initially diagnosed with neuroblastoma.A descriptive study of randomized trials of treatments for childhood acute lymphoblastic leukaemia.Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre.Etoposide quinone is a redox-dependent topoisomerase II poison Long-term risk for subsequent leukemia after treatment for childhood cancer: a report from the Childhood Cancer Survivor Study Second cancers in survivors of childhood cancer.Global characteristics of childhood acute promyelocytic leukemia.Overwhelming primary Epstein-Barr virus infection requiring corticosteroid treatment Management of acute myelogenous leukemia in the elderly.Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group Causes of death in children diagnosed with non-Hodgkin's lymphoma between 1974 and 1985 Acute leukemias with the t(4;11)(q21;q23).Cytogenetic abnormalities in childhood acute lymphoblastic leukemia correlates with clinical features and treatment outcome.Lessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies.Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer.Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor Treatment-related myelodysplastic syndrome/acute myeloid leukemia in survivors of childhood cancer--an update.The risk profile of childhood leukaemia in Greece: a nationwide case-control study

P2860

Q24309063-0F6A267F-0001-4564-A452-E956AE363706 Q24310468-89B4C644-5431-4E61-B83A-353BC9DAA041 Q24654907-F6E6E640-D67A-4CDC-A436-B5E1F500248A Q26849675-3691F631-A2AB-4B84-AD5C-31000ACC876F Q30982315-2EE954AE-C215-45EB-8214-9CABDF4CB118 Q33434899-7EF7E69D-32AC-470B-9CB1-727A9E190C9B Q33624032-6A277626-3B4D-4D6D-85E8-92221A14928E Q33645862-D6FF5B01-2CBA-46B1-8EBB-B048CCE813FE Q33705736-BD9784A9-EB24-4809-A89A-5AF42A973960 Q33707273-9DEA4604-5582-4A25-BC4B-C3E0BF636DC6 Q33735167-A3EF7D7E-D33C-4CAD-A1AD-56A72DFD2CF4 Q33943185-CC22927B-FB28-4E65-89E1-1737E58A4AEA Q33998291-82E6DAB3-DCBC-4A25-BD4F-AC022D124D6A Q34066666-CE7A3ED9-9344-468A-AAB4-BC80621EB666 Q34121459-6D17D50E-801D-4A9A-9F5B-B08D4ECF5B81 Q34121894-6C9DDCB0-FEAC-4F66-AE5E-0637EE73C04D Q34243503-53507D1A-2457-4E82-AD41-AC702E5F337B Q34244453-1D8BD809-11AC-4B61-859D-AE98941CE766 Q34265193-6A7A8294-CC2D-4576-A025-0E02119C12D5 Q34267862-2DBE6D7E-4212-4B76-8AA6-2DAC1A7F28B1 Q34275228-953092D3-AC18-4F78-BA29-EAD093AAB829 Q34637572-562742D2-0FBF-4BBE-97D0-4CD5DB66C439 Q34703990-CF01E40A-E8D2-4BC5-8BC9-92EB7C7E1E4D Q34801486-3A24E11F-2D07-4C8B-8C93-019D82AE8C94 Q34829846-841E7CEB-9A54-4697-8DF1-B3D346FDCD8F Q35058862-F82AAC72-ACAC-4A5A-BD91-E6408241487F Q35067402-9688AB58-2E50-4E1B-ACC9-BA2A36853A05 Q35084794-56FA05B6-65CB-4925-B95F-FFBC8B87DACD Q35231673-51460B28-3F04-4C32-B2A1-B83ACF1C2C8B Q35519951-BEEF84F8-8181-4D9C-837A-94F6AB65DB0E Q35599067-98987D15-266E-4571-97C2-C76173C6AAB6 Q35615792-78296458-9177-4761-BFDA-952E2C3539D7 Q35628171-500C3822-A3FA-4677-85F9-D6E7BC9476DD Q35653559-43CBFE71-BCDE-4CA0-9AD8-CDE4189A6330 Q35664675-0314F81D-1C5C-4FCA-B259-D856DE0586D6 Q35667279-D258B77A-F9D1-4B01-80CE-6C470A7935F8 Q35822033-8E1DF95E-C33B-4092-B651-EAFDF0EFCFAD Q36126134-50CFF841-7E5A-4357-86F4-5CA63DEB51D1 Q36194631-2BEAE920-955F-4848-95C4-F0EB7E17EFF0 Q36431313-734E1B0D-7734-48C3-8CA8-8714D7EEC76B

P2860

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q44461372

description

1991 nî lūn-bûn

@nan

1991年の論文

@ja

1991年学术文章

@wuu

1991年学术文章

@zh-cn

1991年学术文章

@zh-hans

1991年学术文章

@zh-my

1991年学术文章

@zh-sg

1991年學術文章

@yue

1991年學術文章

@zh

1991年學術文章

@zh-hant

name

Acute myeloid leukemia in chil ...... acute lymphoblastic leukemia.

@en

Acute myeloid leukemia in chil ...... acute lymphoblastic leukemia.

@nl

type

label

Acute myeloid leukemia in chil ...... acute lymphoblastic leukemia.

@en

Acute myeloid leukemia in chil ...... acute lymphoblastic leukemia.

@nl

prefLabel

Acute myeloid leukemia in chil ...... acute lymphoblastic leukemia.

@en

Acute myeloid leukemia in chil ...... acute lymphoblastic leukemia.

@nl

P1433

Q44461372-0F61A258-18DE-4D60-88C1-407AF03EC0B8

P1476

Q44461372-CD54FF2F-C63F-4A2D-8D31-BC3F3C008B4E

P2093

Q44461372-1F8F6BE4-2FC7-4DFF-ABB4-37D76E0C6ED9

Q44461372-429BB4E5-ED2E-4C11-8E48-3C1C797F2FCA

Q44461372-511EAD11-F7AC-4F22-8FBE-077C11239685

Q44461372-5F2F20D9-02A2-4E0D-89CB-D5A331F63B3B

Q44461372-70FDC4E9-E38A-40C8-8592-513C13E2B591

Q44461372-8E35E5F2-E822-4B67-82C4-C9EDAB2D0AA0

Q44461372-BFED81C8-9078-43EA-B3E4-17367007673C

Q44461372-CB3231DF-E602-44F8-9668-8379D79B4D86

Q44461372-D708077A-17F1-48EE-A3BD-20134BA05B6B

Q44461372-F0534D09-7231-42E5-B0C6-B4DA5A6BBB58

P304

Q44461372-92C93BCA-E208-4D05-87BA-64555E091A8D

P31

Q44461372-A02D3971-35CF-469B-90C8-2BE0CD436415

P356

Q44461372-EAF26473-8F91-4174-B280-6123501E651C

P407

Q44461372-3D69214C-3728-427C-A94C-B70DC4F6A2F2

P433

Q44461372-813BE57F-E38B-4B63-83DD-63DF17D708DC

P478

Q44461372-2566C6A6-90AB-4F62-8594-C2E6EA5130BE

P577

Q44461372-0ABCEB66-7CBA-4E63-8C72-F682FE83269D

P698

Q44461372-822281DA-43D2-46CE-ADCC-9AC25196B077

P921

Q44461372-43597BC9-A9E7-4AEB-82A7-D04C66139D95

P356

NEJM199112123252402

P1433

The New England Journal of Medicine

P1476

Acute myeloid leukemia in chil ...... acute lymphoblastic leukemia.

@en

P2093

Behm FG

http://www.w3.org/2001/XMLSchema#string

Evans WE

http://www.w3.org/2001/XMLSchema#string

Hancock ML

http://www.w3.org/2001/XMLSchema#string

Head DR

http://www.w3.org/2001/XMLSchema#string

Mahmoud MH

http://www.w3.org/2001/XMLSchema#string

Pui CH

http://www.w3.org/2001/XMLSchema#string

Raimondi SC

http://www.w3.org/2001/XMLSchema#string

Ribeiro RC

http://www.w3.org/2001/XMLSchema#string

Rivera GK

http://www.w3.org/2001/XMLSchema#string

Sandlund JT

http://www.w3.org/2001/XMLSchema#string

P304

1682-1687

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJM199112123252402

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

325

http://www.w3.org/2001/XMLSchema#string

P577

1991-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1944468

http://www.w3.org/2001/XMLSchema#string

P921